A Phase II, Trial of Chloroquine in Combination With VELCADE and Cyclophosphamide in Patients With Relapsed and Refractory Myeloma.

Trial Profile

A Phase II, Trial of Chloroquine in Combination With VELCADE and Cyclophosphamide in Patients With Relapsed and Refractory Myeloma.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2016

At a glance

  • Drugs Bortezomib (Primary) ; Chloroquine; Cyclophosphamide
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Mar 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 16 Jun 2014 Planned End Date changed from 1 Oct 2016 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
    • 16 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top